354 related articles for article (PubMed ID: 33003492)
1. The Old and the New: Prospects for Non-Integrating Lentiviral Vector Technology.
Luis A
Viruses; 2020 Sep; 12(10):. PubMed ID: 33003492
[TBL] [Abstract][Full Text] [Related]
2. Non-integrating lentiviral vectors.
Sarkis C; Philippe S; Mallet J; Serguera C
Curr Gene Ther; 2008 Dec; 8(6):430-7. PubMed ID: 19075626
[TBL] [Abstract][Full Text] [Related]
3. Stable gene transfer to muscle using non-integrating lentiviral vectors.
Apolonia L; Waddington SN; Fernandes C; Ward NJ; Bouma G; Blundell MP; Thrasher AJ; Collins MK; Philpott NJ
Mol Ther; 2007 Nov; 15(11):1947-54. PubMed ID: 17700544
[TBL] [Abstract][Full Text] [Related]
4. Non-integrating lentiviral vectors based on the minimal S/MAR sequence retain transgene expression in dividing cells.
Xu Z; Chen F; Zhang L; Lu J; Xu P; Liu G; Xie X; Mu W; Wang Y; Liu D
Sci China Life Sci; 2016 Oct; 59(10):1024-1033. PubMed ID: 27614752
[TBL] [Abstract][Full Text] [Related]
5. Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives.
Dong W; Kantor B
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372494
[TBL] [Abstract][Full Text] [Related]
6. Evaluating Nonintegrating Lentiviruses as Safe Vectors for Noninvasive Reporter-Based Molecular Imaging of Multipotent Mesenchymal Stem Cells.
Hamilton AM; Foster PJ; Ronald JA
Hum Gene Ther; 2018 Oct; 29(10):1213-1225. PubMed ID: 30101620
[TBL] [Abstract][Full Text] [Related]
7. A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells.
Vijayraghavan S; Kantor B
J Vis Exp; 2017 Dec; (130):. PubMed ID: 29286484
[TBL] [Abstract][Full Text] [Related]
8. Transient Expression of Green Fluorescent Protein in Integrase-Defective Lentiviral Vector-Transduced 293T Cell Line.
Nordin F; Hamid ZA; Chan L; Farzaneh F; Hamid MK
Methods Mol Biol; 2016; 1448():159-73. PubMed ID: 27317180
[TBL] [Abstract][Full Text] [Related]
9. Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo.
Philippe S; Sarkis C; Barkats M; Mammeri H; Ladroue C; Petit C; Mallet J; Serguera C
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17684-9. PubMed ID: 17095605
[TBL] [Abstract][Full Text] [Related]
10. Episomal lentiviral vectors confer erythropoietin expression in dividing cells.
Chen F; Qi X; Zhang R; Wu ZY; Yan CE; Li J; Liu QY; Qi J
Plasmid; 2017 Mar; 90():15-19. PubMed ID: 28189631
[TBL] [Abstract][Full Text] [Related]
11. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
12. Integrase-defective lentiviral vectors: progress and applications.
Banasik MB; McCray PB
Gene Ther; 2010 Feb; 17(2):150-7. PubMed ID: 19847206
[TBL] [Abstract][Full Text] [Related]
13. Integrase defective, nonintegrating lentiviral vectors.
Michelini Z; Negri D; Cara A
Methods Mol Biol; 2010; 614():101-10. PubMed ID: 20225038
[TBL] [Abstract][Full Text] [Related]
14. Integrase-defective lentiviral vectors--a stage for nonviral integration machineries.
Staunstrup NH; Mikkelsen JG
Curr Gene Ther; 2011 Oct; 11(5):350-62. PubMed ID: 21745178
[TBL] [Abstract][Full Text] [Related]
15. HIV-1-based lentiviral vectors.
Liu YP; Berkhout B
Methods Mol Biol; 2014; 1087():273-84. PubMed ID: 24158830
[TBL] [Abstract][Full Text] [Related]
16. Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors.
Wang X; Wang Y; Wu X; Wang J; Wang Y; Qiu Z; Chang T; Huang H; Lin RJ; Yee JK
Nat Biotechnol; 2015 Feb; 33(2):175-8. PubMed ID: 25599175
[TBL] [Abstract][Full Text] [Related]
17. Integrase deficient lentiviral vector: prospects for safe clinical applications.
Yew CT; Gurumoorthy N; Nordin F; Tye GJ; Wan Kamarul Zaman WS; Tan JJ; Ng MH
PeerJ; 2022; 10():e13704. PubMed ID: 35979475
[TBL] [Abstract][Full Text] [Related]
18. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
[TBL] [Abstract][Full Text] [Related]
19. Safe engineering of CAR T cells for adoptive cell therapy of cancer using long-term episomal gene transfer.
Jin C; Fotaki G; Ramachandran M; Nilsson B; Essand M; Yu D
EMBO Mol Med; 2016 Jul; 8(7):702-11. PubMed ID: 27189167
[TBL] [Abstract][Full Text] [Related]
20. Strategies for targeting lentiviral vectors.
Frecha C; Szécsi J; Cosset FL; Verhoeyen E
Curr Gene Ther; 2008 Dec; 8(6):449-60. PubMed ID: 19075628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
